Developer docs
API playgroundTry for free, no card

Search company profiles

Adaptive Testing Technologies

Full company profile

uuid000b4g6

Namestring
Adaptive Testing Technologies
Legal namestring
Adaptive Testing Technologies, Inc.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Adaptive Testing Technologies, Inc. (ATT) is a Chicago-based private health technology company founded in 2011 that develops computerized adaptive testing (CAT) software for mental and behavioral health assessment. Its core products — CAT-MH® for adults and K-CAT® for children ages 7-17 — use multi-dimensional item response theory (MIRT) to adaptively select items from calibrated banks of approximately 1,500 and 2,120 items respectively, producing severity scores for depression, anxiety, suicidality, PTSD, substance use disorder, psychosis, mania/hypomania, ADHD, and social determinants of health in roughly 2 minutes per module. Both suites are validated against structured clinical diagnostic interviews (SCID-DSM-5) and are deployed on a HIPAA-secure AWS cloud with HITRUST certification, accessible via API, and integrated with Epic EHR (deployed at the University of Chicago). The company also offers the CASSY tool and the pCAT-COG prototype for cognitive assessment.

ATT generates revenue through subscription-based enterprise licensing to institutional buyers — hospitals, emergency departments, insurers, managed care organizations, university counseling systems, state agencies, and first-responder departments — with custom multi-year contracts sold through direct enterprise sales and, since July 2025, through a distribution partnership with Pearson Assessments on the Q-global® platform. The go-to-market is content- and research-led (peer-reviewed publications, webinars, LinkedIn, newsletter), targeting clinical administrators and public health officials rather than end consumers, with sales conducted exclusively through licensed healthcare professionals and authorized administrators. Strategic priorities visible in 2025 include expanding into cognitive assessment (pCAT-COG), embedding in Epic-based health systems, broadening into first-responder and state-government verticals, and scaling distribution through Pearson.

Short descriptiontext

Adaptive Testing Technologies develops computerized adaptive tests for mental health (CAT-MH® for adults, K-CAT® for children) and cognitive function, selling subscription enterprise software to hospitals, insurers, government agencies, universities, and first-responder organizations via direct sales and the Pearson Q-global® platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computerized adaptive testing, mental health assessment, behavioral health screening, clinical decision support, patient-reported outcomes
Industry1 code
PRIMARYEDAFADAD
Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms
Education/Education Technology (EdTech) & Digital Learning/Assessment, Testing, Proctoring & Credentialing Platforms
NAICS code1 code
  • Other Computer Related Services541519
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Mental Health Assessment Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS / Software Licensing for Mental Health Assessments
TypeSubscription Recurring
Description

Adaptive Testing Technologies generates revenue by providing computerized adaptive mental health assessment software (CAT-MH® and K-CAT®) to licensed healthcare professionals, hospitals, insurance companies, managed care organizations, and other authorized administrators. The company offers its tools via a cloud-based platform with API integration capabilities. Based on the enterprise sales motion (Request a Demo, licensed administrator requirement), the revenue model is subscription-based software licensing to institutional buyers.

adaptivetestingtechnologies.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise / Institutional Licensing (custom pricing)
ModelSubscriptionBilling cadenceMulti-year contract
Notes

No public pricing listed. Sales conducted through authorized administrator accounts. Custom enterprise pricing based on organization type and volume. Contact: info@adaptivetestingtechnologies.com or +1 (312) 878-6490.

adaptivetestingtechnologies.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1CAT-MH®
Description

Computerized Adaptive Tests for Mental Health - a suite of measures validated for depression, anxiety, mania/hypomania, substance use disorder, psychosis, PTSD, social determinants of health, adult ADHD, and suicidality in adults.

adaptivetestingtechnologies.com
+2 more records
Core offering1 text field

Adaptive Testing Technologies designs, validates, and licenses computerized adaptive testing software for mental and behavioral health assessment. Its CAT-MH® suite screens adults for nine-plus conditions in roughly two minutes per module using MIRT-based adaptive item selection, and its K-CAT® product provides an equivalent children's battery for ages 7–17. The tools are sold to licensed clinicians, hospitals, insurers, managed care organizations, government agencies, universities, and law enforcement via a HIPAA-secure AWS cloud platform with Epic EHR API integration.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 2.5-fold increase in identification of moderate-to-severe depression compared to visit-based screening (PORTAL-Depression Study)
+6 more records
Product overview1 text field

Adaptive Testing Technologies offers a platform of computerized adaptive testing products for mental and behavioral health assessment. The core offerings are the CAT-MH® suite for adults and K-CAT® for children ages 7-17, both utilizing multi-dimensional item response theory (MIRT) to adaptively select items from large banks (1,500+ items for adults, 2,120 for children). The CAT-MH® and K-CAT® platforms can administer individual modules targeting specific conditions (depression, anxiety, substance use disorder, suicidality, PTSD, etc.) or full batteries. Additionally, the company is developing the pCAT-COG for cognitive assessment and offers the CASSY tool. All assessments are cloud-based, HIPAA-secure, and can be integrated via API into electronic health records.

Product and service4 records
1CAT-MH® (Computerized Adaptive Test for Mental Health)
CategoryMental Health Assessment Software
Description

A suite of computerized adaptive mental health assessments for adults, validated against structured clinical diagnostic interviews (SCID-DSM-5). Using multi-dimensional item response theory (MIRT), the platform adaptively selects items from a bank of approximately 1,500 items and screens for depression, anxiety, mania/hypomania, substance use disorder, psychosis, PTSD, social determinants of health, adult ADHD, and suicidality in approximately 2 minutes per module. Sold to licensed clinicians, hospitals, insurers, managed care, and government entities via cloud delivery and EHR integration. Available in English, Spanish, and Chinese with selectable audio for literacy support.

2K-CAT® (Kiddie-Computerized Adaptive Test)
CategoryMental Health Assessment Software
Description

A children's version of CAT-MH® validated for youth ages 7 to 17, with both self-rated and parent/caregiver-rated modules covering depression, anxiety, mania/hypomania, ADHD, substance use disorder, conduct disorder, ODD, PTSD, and suicidality. Uses a separate item bank of 2,120 items and is administered in approximately 2 minutes per module. Available in English and Spanish with selectable audio. Sold to pediatric EDs, child welfare agencies, university counseling systems, and community mental health providers.

3CASSY
CategoryMental Health Assessment Software
Description

An additional assessment tool offered by Adaptive Testing Technologies alongside CAT-MH® and K-CAT® to support mental health screening and measurement-based care.

4pCAT-COG (prototype Computerized Adaptive Test for Cognitive Function)
CategoryCognitive Assessment Software
Description

A prototype computerized adaptive cognitive assessment tool using multi-dimensional item response theory for early detection of cognitive decline. Evaluates global cognitive function and five domains (episodic memory, semantic memory/language, working memory, executive function/flexible thinking, processing speed) using 57 items calibrated with a bifactor MIRT model. Differentiates individuals with mild cognitive impairment (MCI) from those without cognitive impairment using only 11 items.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-07-10
Description

Pearson is partnering with Adaptive Testing Technologies to bring the CAT-MH® and K-CAT® mental and behavioral health assessments to the Q-global® platform. This partnership expands distribution of ATT's assessment tools through Pearson's established global assessment platform, targeting institutional buyers in education, healthcare, and corporate wellness markets.

Strategic tierCoreTypeTechnology or Integration
Description

Adaptive Testing Technologies has fully integrated the CAT-MH® into the Epic EHR at the University of Chicago and developed clinical workflows designed around the integration. This enables seamless inclusion of CAT-MH® assessments within the Epic clinical environment, with results exportable and viewable directly within the EHR.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

The CAT-MH® is being used as the 1st-stage diagnostic screener in the largest national survey of mental health and substance use disorders in history, conducted by SAMHSA (Substance Abuse and Mental Health Services Administration) and implemented by RTI International.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Chicago conducted a CAT-MH® study of 1,000 patients in the emergency department, screened for depression using CAD-MDD and CAT-DI. The university also completed full Epic EHR integration of CAT-MH® and is home to company founder Robert Gibbons and other key collaborators.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Researchers at NYU Grossman School of Medicine conducted a study of K-CAT® effectiveness in two high-volume pediatric emergency departments, demonstrating that K-CAT® identified significantly more youth at risk for suicide than standard C-SSRS screening.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Researchers at VCU, including Dr. Paige Cervantes (Department of Psychiatry), led the pilot study 'Perspectives on the K-CAT-SS for Autistic Youth' evaluating K-CAT® for suicide risk assessment in autistic youth aged 7-17.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Pearson operates the Q-global® digital assessment platform, which hosts a broad portfolio of standardized clinical and educational assessments. Pearson is both a distribution partner and the most significant incumbent in the digital psychometric assessment space, with overlapping clinician customers and a competing product roadmap.

TypeDirect peer
Description

MHS publishes a wide range of computerized psychological and behavioral assessments distributed to clinicians, schools, and researchers. Like ATT, it sells evidence-based assessment instruments with a digital delivery model and shares overlap in clinical and research customer segments.

TypeDirect peer
Description

PAR develops, publishes, and distributes standardized psychological assessment instruments used by clinicians, schools, and researchers. Its product portfolio and digital delivery overlap directly with ATT's CAT-MH® and K-CAT®, particularly in mental health screening and outcome measurement.

TypeDirect peer
Description

Creyos (formerly Cambridge Brain Sciences) provides computerized cognitive and behavioral health assessments delivered via web-based platforms to clinicians, researchers, and direct-to-consumer channels. It is one of the closest direct competitors in computerized adaptive-style assessment for mental and cognitive health.

TypeDirect peer
Description

CNS Vital Signs offers a computerized neurocognitive assessment battery used by clinicians and researchers to evaluate cognitive function and mental health symptoms. It competes in the same computerized clinical-assessment category as ATT, particularly in primary care, behavioral health, and research settings.

TypeDirect peer
Description

Cambridge Cognition develops digital cognitive assessment tools (including CANTAB) for clinical trials, healthcare providers, and research institutions. Its focus on computerized assessment validated against clinical endpoints is highly comparable to ATT's psychometric validation approach.

TypeEmerging player
Description

BrainCheck provides rapid computerized cognitive assessment tools targeting concussion, dementia, and general cognitive health. It overlaps with ATT's emerging pCAT-COG cognitive assessment line, although it is earlier-stage and focused primarily on clinical neurology and primary care.

TypeBroad incumbent
Description

Quartet Health is a behavioral health platform that coordinates mental health referrals and measurement-based care between primary care and behavioral health providers. It competes for the same institutional buyer (payers, health systems) seeking population-level mental health quality and outcomes improvement.

TypeBroad incumbent
Description

Lyra Health is a mental health benefits platform offering therapy, coaching, and assessment services to enterprise employers and payers. While primarily a care-delivery platform, it overlaps with ATT in serving enterprise buyers seeking validated mental health measurement and outcomes data.

10Mindstrong (defunct asset / Pear Therapeutics-adjacent)
TypeOthers
Description

While Mindstrong itself shut down, Pear Therapeutics pioneered prescription digital therapeutics (PDTs) for mental and behavioral health and represents the broader category of clinically validated, FDA-cleared software used in mental health treatment. It is a thematic peer signaling both the opportunity and difficulty of building a clinically validated mental-health software business.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Adaptive Testing Technologies

Mental Health Assessment Softwareadaptivetestingtechnologies.com

Adaptive Testing Technologies develops computerized adaptive tests for mental health (CAT-MH® for adults, K-CAT® for children) and cognitive function, selling subscription enterprise software to hospitals, insurers, government agencies, universities, and first-responder organizations via direct sales and the Pearson Q-global® platform.

What Adaptive Testing Technologies does

Adaptive Testing Technologies, Inc. (ATT) is a Chicago-based private health technology company founded in 2011 that develops computerized adaptive testing (CAT) software for mental and behavioral health assessment. Its core products — CAT-MH® for adults and K-CAT® for children ages 7-17 — use multi-dimensional item response theory (MIRT) to adaptively select items from calibrated banks of approximately 1,500 and 2,120 items respectively, producing severity scores for depression, anxiety, suicidality, PTSD, substance use disorder, psychosis, mania/hypomania, ADHD, and social determinants of health in roughly 2 minutes per module. Both suites are validated against structured clinical diagnostic interviews (SCID-DSM-5) and are deployed on a HIPAA-secure AWS cloud with HITRUST certification, accessible via API, and integrated with Epic EHR (deployed at the University of Chicago). The company also offers the CASSY tool and the pCAT-COG prototype for cognitive assessment.

ATT generates revenue through subscription-based enterprise licensing to institutional buyers — hospitals, emergency departments, insurers, managed care organizations, university counseling systems, state agencies, and first-responder departments — with custom multi-year contracts sold through direct enterprise sales and, since July 2025, through a distribution partnership with Pearson Assessments on the Q-global® platform. The go-to-market is content- and research-led (peer-reviewed publications, webinars, LinkedIn, newsletter), targeting clinical administrators and public health officials rather than end consumers, with sales conducted exclusively through licensed healthcare professionals and authorized administrators. Strategic priorities visible in 2025 include expanding into cognitive assessment (pCAT-COG), embedding in Epic-based health systems, broadening into first-responder and state-government verticals, and scaling distribution through Pearson.

Adaptive Testing Technologies firmographics

Firmographics
Name
Adaptive Testing Technologies
Legal name
Adaptive Testing Technologies, Inc.
Website
https://adaptivetestingtechnologies.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Adaptive Testing Technologies develops computerized adaptive tests for mental health (CAT-MH® for adults, K-CAT® for children) and cognitive function, selling subscription enterprise software to hospitals, insurers, government agencies, universities, and first-responder organizations via direct sales and the Pearson Q-global® platform.
Ownership category
akta.pro rank

Adaptive Testing Technologies industry classification

Industry
Product category
Mental Health Assessment Software
NAICS
Other Computer Related Services (541519)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYEDAFADAD
Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms
Education/Education Technology (EdTech) & Digital Learning/Assessment, Testing, Proctoring & Credentialing Platforms

Keywords

  • Computerized adaptive testing
  • Mental health assessment
  • Behavioral health screening
  • Clinical decision support
  • Patient-reported outcomes

Where Adaptive Testing Technologies is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Adaptive Testing Technologies business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SaaS / Software Licensing for Mental Health Assessments: Adaptive Testing Technologies generates revenue by providing computerized adaptive mental health assessment software (CAT-MH® and K-CAT®) to licensed healthcare professionals, hospitals, insurance companies, managed care organizations, and other authorized administrators. The company offers its tools via a cloud-based platform with API integration capabilities. Based on the enterprise sales motion (Request a Demo, licensed administrator requirement), the revenue model is subscription-based software licensing to institutional buyers.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise / Institutional Licensing (custom pricing)

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Adaptive Testing Technologies product offering

Product offering

Core offering

Adaptive Testing Technologies designs, validates, and licenses computerized adaptive testing software for mental and behavioral health assessment. Its CAT-MH® suite screens adults for nine-plus conditions in roughly two minutes per module using MIRT-based adaptive item selection, and its K-CAT® product provides an equivalent children's battery for ages 7–17. The tools are sold to licensed clinicians, hospitals, insurers, managed care organizations, government agencies, universities, and law enforcement via a HIPAA-secure AWS cloud platform with Epic EHR API integration.

Product overview

Adaptive Testing Technologies offers a platform of computerized adaptive testing products for mental and behavioral health assessment. The core offerings are the CAT-MH® suite for adults and K-CAT® for children ages 7-17, both utilizing multi-dimensional item response theory (MIRT) to adaptively select items from large banks (1,500+ items for adults, 2,120 for children). The CAT-MH® and K-CAT® platforms can administer individual modules targeting specific conditions (depression, anxiety, substance use disorder, suicidality, PTSD, etc.) or full batteries. Additionally, the company is developing the pCAT-COG for cognitive assessment and offers the CASSY tool. All assessments are cloud-based, HIPAA-secure, and can be integrated via API into electronic health records.

Differentiator

Problem solved

Functional benefit

Brands

  • CAT-MH®: Computerized Adaptive Tests for Mental Health - a suite of measures validated for depression, anxiety, mania/hypomania, substance use disorder, psychosis, PTSD, social determinants of health, adult ADHD, and suicidality in adults.
  • K-CAT®
  • CASSY

Products and services

  • CAT-MH® (Computerized Adaptive Test for Mental Health) A suite of computerized adaptive mental health assessments for adults, validated against structured clinical diagnostic interviews (SCID-DSM-5). Using multi-dimensional item response theory (MIRT), the platform adaptively selects items from a bank of approximately 1,500 items and screens for depression, anxiety, mania/hypomania, substance use disorder, psychosis, PTSD, social determinants of health, adult ADHD, and suicidality in approximately 2 minutes per module. Sold to licensed clinicians, hospitals, insurers, managed care, and government entities via cloud delivery and EHR integration. Available in English, Spanish, and Chinese with selectable audio for literacy support.
  • K-CAT® (Kiddie-Computerized Adaptive Test) A children's version of CAT-MH® validated for youth ages 7 to 17, with both self-rated and parent/caregiver-rated modules covering depression, anxiety, mania/hypomania, ADHD, substance use disorder, conduct disorder, ODD, PTSD, and suicidality. Uses a separate item bank of 2,120 items and is administered in approximately 2 minutes per module. Available in English and Spanish with selectable audio. Sold to pediatric EDs, child welfare agencies, university counseling systems, and community mental health providers.
  • CASSY An additional assessment tool offered by Adaptive Testing Technologies alongside CAT-MH® and K-CAT® to support mental health screening and measurement-based care.
  • pCAT-COG (prototype Computerized Adaptive Test for Cognitive Function) A prototype computerized adaptive cognitive assessment tool using multi-dimensional item response theory for early detection of cognitive decline. Evaluates global cognitive function and five domains (episodic memory, semantic memory/language, working memory, executive function/flexible thinking, processing speed) using 57 items calibrated with a bifactor MIRT model. Differentiates individuals with mild cognitive impairment (MCI) from those without cognitive impairment using only 11 items.

Quantifiable outcome

  • 2.5-fold increase in identification of moderate-to-severe depression compared to visit-based screening (PORTAL-Depression Study)
  • +6 more outcomes

Companies that use Adaptive Testing Technologies

Customer profile

Named customers6 records

Segments6 records

Ideal customer profiles5 records

Adaptive Testing Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature5 records

Adaptive Testing Technologies partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core.

  • Pearson AssessmentscoreChannel Partner/ Reseller/ Distributor · 10 July 2025Pearson is partnering with Adaptive Testing Technologies to bring the CAT-MH® and K-CAT® mental and behavioral health assessments to the Q-global® platform. This partnership expands distribution of ATT's assessment tools through Pearson's established global assessment platform, targeting institutional buyers in education, healthcare, and corporate wellness markets.
  • Epic Systems (EHR Integration)coreTechnology or IntegrationAdaptive Testing Technologies has fully integrated the CAT-MH® into the Epic EHR at the University of Chicago and developed clinical workflows designed around the integration. This enables seamless inclusion of CAT-MH® assessments within the Epic clinical environment, with results exportable and viewable directly within the EHR.
  • SAMHSA / RTI InternationalcoreStrategic or Co-development PartnerThe CAT-MH® is being used as the 1st-stage diagnostic screener in the largest national survey of mental health and substance use disorders in history, conducted by SAMHSA (Substance Abuse and Mental Health Services Administration) and implemented by RTI International.
  • University of ChicagocoreStrategic or Co-development PartnerUniversity of Chicago conducted a CAT-MH® study of 1,000 patients in the emergency department, screened for depression using CAD-MDD and CAT-DI. The university also completed full Epic EHR integration of CAT-MH® and is home to company founder Robert Gibbons and other key collaborators.
  • NYU Grossman School of MedicinecoreStrategic or Co-development PartnerResearchers at NYU Grossman School of Medicine conducted a study of K-CAT® effectiveness in two high-volume pediatric emergency departments, demonstrating that K-CAT® identified significantly more youth at risk for suicide than standard C-SSRS screening.
  • Virginia Commonwealth University (VCU)coreStrategic or Co-development PartnerResearchers at VCU, including Dr. Paige Cervantes (Department of Psychiatry), led the pilot study 'Perspectives on the K-CAT-SS for Autistic Youth' evaluating K-CAT® for suicide risk assessment in autistic youth aged 7-17.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Adaptive Testing Technologies competitors and assessment

Company assessment

Broad incumbents

  • Pearson Clinical Assessments: Pearson operates the Q-global® digital assessment platform, which hosts a broad portfolio of standardized clinical and educational assessments. Pearson is both a distribution partner and the most significant incumbent in the digital psychometric assessment space, with overlapping clinician customers and a competing product roadmap.
  • Quartet Health: Quartet Health is a behavioral health platform that coordinates mental health referrals and measurement-based care between primary care and behavioral health providers. It competes for the same institutional buyer (payers, health systems) seeking population-level mental health quality and outcomes improvement.
  • Lyra Health: Lyra Health is a mental health benefits platform offering therapy, coaching, and assessment services to enterprise employers and payers. While primarily a care-delivery platform, it overlaps with ATT in serving enterprise buyers seeking validated mental health measurement and outcomes data.

Direct peers

  • Multi-Health Systems (MHS): MHS publishes a wide range of computerized psychological and behavioral assessments distributed to clinicians, schools, and researchers. Like ATT, it sells evidence-based assessment instruments with a digital delivery model and shares overlap in clinical and research customer segments.
  • Psychological Assessment Resources (PAR): PAR develops, publishes, and distributes standardized psychological assessment instruments used by clinicians, schools, and researchers. Its product portfolio and digital delivery overlap directly with ATT's CAT-MH® and K-CAT®, particularly in mental health screening and outcome measurement.
  • Creyos Health: Creyos (formerly Cambridge Brain Sciences) provides computerized cognitive and behavioral health assessments delivered via web-based platforms to clinicians, researchers, and direct-to-consumer channels. It is one of the closest direct competitors in computerized adaptive-style assessment for mental and cognitive health.
  • CNS Vital Signs: CNS Vital Signs offers a computerized neurocognitive assessment battery used by clinicians and researchers to evaluate cognitive function and mental health symptoms. It competes in the same computerized clinical-assessment category as ATT, particularly in primary care, behavioral health, and research settings.
  • Cambridge Cognition: Cambridge Cognition develops digital cognitive assessment tools (including CANTAB) for clinical trials, healthcare providers, and research institutions. Its focus on computerized assessment validated against clinical endpoints is highly comparable to ATT's psychometric validation approach.

Emerging players

  • BrainCheck: BrainCheck provides rapid computerized cognitive assessment tools targeting concussion, dementia, and general cognitive health. It overlaps with ATT's emerging pCAT-COG cognitive assessment line, although it is earlier-stage and focused primarily on clinical neurology and primary care.

Others

  • Mindstrong (defunct asset / Pear Therapeutics-adjacent): While Mindstrong itself shut down, Pear Therapeutics pioneered prescription digital therapeutics (PDTs) for mental and behavioral health and represents the broader category of clinically validated, FDA-cleared software used in mental health treatment. It is a thematic peer signaling both the opportunity and difficulty of building a clinically validated mental-health software business.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Adaptive Testing Technologies social profiles

Digital presence

Adaptive Testing Technologies compliance and trust

Trust signal

Compliance2 records

Adaptive Testing Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Adaptive Testing Technologies leadership team

Management profile

Number of profiles

Profiles20 records

Adaptive Testing Technologies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Adaptive Testing Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adaptive Testing Technologies

What does Adaptive Testing Technologies do?

Adaptive Testing Technologies designs, validates, and licenses computerized adaptive testing software for mental and behavioral health assessment. Its CAT-MH® suite screens adults for nine-plus conditions in roughly two minutes per module using MIRT-based adaptive item selection, and its K-CAT® product provides an equivalent children's battery for ages 7–17. The tools are sold to licensed clinicians, hospitals, insurers, managed care organizations, government agencies, universities, and law enforcement via a HIPAA-secure AWS cloud platform with Epic EHR API integration.

Is Adaptive Testing Technologies a public or private company?

Adaptive Testing Technologies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Adaptive Testing Technologies founded?

Adaptive Testing Technologies was founded in 2016. It employs 1 to 10 people.

Where is Adaptive Testing Technologies based?

Adaptive Testing Technologies is headquartered in Chicago, United States, in the North America region.

How does Adaptive Testing Technologies make money?

One revenue line is on record: saaS / Software Licensing for Mental Health Assessments.

Who are Adaptive Testing Technologies's main competitors?

Broad incumbents on record are Pearson Clinical Assessments, Quartet Health and Lyra Health. Direct peers are Multi-Health Systems (MHS), Psychological Assessment Resources (PAR), Creyos Health, CNS Vital Signs and Cambridge Cognition. BrainCheck is listed as an emerging player. Mindstrong (defunct asset / Pear Therapeutics-adjacent) is listed as an others.

Does Adaptive Testing Technologies have an API?

Yes. The CAT-MH® and K-CAT® can be leveraged via API for integration into Electronic Health Records. The tools are scalable to any size population via a HIPAA secure Amazon Web Services (AWS) platform. The assessment process can be streamlined by integrating with the API, allowing for remote delivery of assessments, result notifications, and EHR integration.

What industry is Adaptive Testing Technologies in?

Adaptive Testing Technologies's product category is Mental Health Assessment Software. Its primary akta.pro industry code is EDAFADAD, Computerized Adaptive Testing (CAT) & Psychometric Analytics Platforms. Its NAICS code is 541519 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireResearchers from the Veteran's Health Administration, Academia, and Adaptive Testing Technologies Validate the Computerized Adaptive Test Suicide Scale (CAT-SS) for U.S. Military VeteransAdaptive Testing Technologies and researchers from the Veterans Health Administration validated the Computerized Adaptive Test Suicide Scale (CAT-SS), demonstrating its superior predictive accuracy for suicide risk compared to current clinical standards. The study, published in PLOS ONE, indicates that the tool can rapidly assess veterans' suicide risk severity with high precision when integrated into electronic medical records. Findings suggest this implementation could significantly improve early detection and personalized screening for suicidal ideation and behavior among military personnel.PR NewswireAdaptive Testing Technologies Announces Screener to Help Identify Youth At-Risk of Suicide: Available for LicenseAdaptive Testing Technologies announced the availability for license of CASSY, a computerized adaptive screen designed to identify youth at risk of suicide in pediatric emergency departments. The tool, developed with support from the National Institute of Mental Health and validated through studies involving U.S. emergency departments, demonstrated high sensitivity and specificity in predicting future suicide attempts within three months.PR NewswireResearchers from the Veterans Administration, Academia, and Adaptive Testing Technologies Develop and Validate New Rapid PTSD Computerized Adaptive Assessment Tools for U.S. Military VeteransResearchers from the Veterans Administration and academic institutions, in partnership with Adaptive Testing Technologies, validated two new computerized adaptive assessment tools for diagnosing PTSD in U.S. military veterans. Published in JAMA Network Open, the study demonstrates that these tools offer diagnostic accuracy comparable to the clinical gold standard while significantly reducing administration time and burden.